| IL‐22 and non‐ELR‐CXC chemokine expression in chronic hepatitis B virus‐infected liver X Xiang, H Gui, NJC King, L Cole, H Wang, Q Xie, S Bao Immunology and cell biology 90 (6), 611-619, 2012 | 87 | 2012 |
| Protective effect of Th22 cells and intrahepatic IL-22 in drug induced hepatocellular injury R Lai, X Xiang, R Mo, R Bao, P Wang, S Guo, G Zhao, H Gui, H Wang, ... Journal of hepatology 63 (1), 148-155, 2015 | 71 | 2015 |
| Interleukin-22 from bench to bedside: a promising drug for epithelial repair B Gao, X Xiang Cellular & Molecular Immunology 16 (7), 666-667, 2019 | 58 | 2019 |
| Enhanced autophagy contributes to protective effects of IL-22 against acetaminophen-induced liver injury R Mo, R Lai, J Lu, Y Zhuang, T Zhou, S Jiang, P Ren, Z Li, Z Cao, Y Liu, ... Theranostics 8 (15), 4170, 2018 | 57 | 2018 |
| IL‐35: a potential therapeutic target for controlling hepatitis B virus infection XG Xiang, Q Xie Journal of digestive diseases 16 (1), 1-6, 2015 | 54 | 2015 |
| Characterisation of IL-22 and interferon-gamma-inducible chemokines in human carotid plaque Q Xia, X Xiang, S Patel, R Puranik, Q Xie, S Bao International journal of cardiology 154 (2), 187-189, 2012 | 39 | 2012 |
| Persistently elevated circulating Th22 reversely correlates with prognosis in HBV‐related acute‐on‐chronic liver failure R Mo, P Wang, R Lai, F Li, Y Liu, S Jiang, G Zhao, S Guo, H Zhou, L Lin, ... Journal of Gastroenterology and hepatology 32 (3), 677-686, 2017 | 30 | 2017 |
| Genetic variations of NTCP are associated with susceptibility to HBV infection and related hepatocellular carcinoma P Wang, R Mo, R Lai, Y Xu, J Lu, G Zhao, Y Liu, Z Cao, X Wang, Z Li, ... Oncotarget 8 (62), 105407, 2017 | 23 | 2017 |
| MAIT cells: a novel therapeutic target for alcoholic liver disease? B Gao, J Ma, X Xiang Gut 67 (5), 784-786, 2018 | 18 | 2018 |
| Viral sequence evolution in Chinese genotype 1b chronic hepatitis C patients experiencing unsuccessful interferon treatment X Xiang, J Lu, Z Dong, H Zhou, W Tao, Q Guo, X Zhou, S Bao, Q Xie, ... Infection, Genetics and Evolution 11 (2), 382-390, 2011 | 12 | 2011 |
| Younger trend of cirrhosis incidence in genotype 3 HCV infected patients in Eastern China J Lu, X Xiang, Z Cao, W Wang, G Zhao, W Tang, L Chen, S Guo, ... Journal of Medical Virology 89 (11), 1973-1980, 2017 | 8 | 2017 |
| Randomized clinical trial: Nucleos (t) ide analogues improved survival of CHB-related HCC patients via reducing severity and progression of malignancy Y Wang, X Xiang, L Chen, Z Cao, R Bao, H Zhou, W Tang, J Lu, L Lin, ... Oncotarget 7 (36), 58553, 2016 | 8 | 2016 |
| A five years study of antiviral effect of entecavir in Chinese chronic hepatitis B patients K Liu, X Xiang, R Bao, R Chen, Y Liu, J Xie, Q Guo, S Bao, Q Xie, H Wang Scientific reports 6 (1), 28779, 2016 | 4 | 2016 |
